These results suggest that unknown mechanisms of FSH in relation to energy metabolism, including fat and glucose metabolisms, may shed light on the effects of FSH on metabolic risk factors associated with MetS and cardiovascular disease. The gene discussed is BRD2; the disease is metabolic syndrome.